scholarly article | Q13442814 |
P50 | author | Michael Berger | Q86559023 |
P2093 | author name string | Oren Rom | |
John S Parks | |||
Abraham K Gebre | |||
Michael Aviram | |||
Ibrahim Omar | |||
Leonor Cohen-Daniel | |||
P2860 | cites work | Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity | Q36839721 |
Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism | Q36852748 | ||
Lipid rafts in T cell signalling and disease | Q36949374 | ||
LXR signaling couples sterol metabolism to proliferation in the acquired immune response. | Q37061238 | ||
Cellular cholesterol trafficking and compartmentalization | Q37064008 | ||
GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice | Q37170811 | ||
An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance | Q37217188 | ||
Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells | Q37899120 | ||
CD8 T cell quiescence revisited | Q37987729 | ||
Metabolic pathways in immune cell activation and quiescence | Q38100361 | ||
15-Lipoxygenase inhibitors: a patent review | Q38631240 | ||
Novel transcriptional regulation of the schlafen-2 gene in macrophages in response to TLR-triggered stimulation | Q40145821 | ||
Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and a | Q40542044 | ||
Loss of T-cell quiescence by targeting Slfn2 prevents the development and progression of T-ALL. | Q40857983 | ||
Schlafen2 mutation unravels a role for chronic ER stress in the loss of T cell quiescence | Q41896082 | ||
Adipocyte Metrnl Antagonizes Insulin Resistance Through PPARγ Signaling. | Q42823688 | ||
Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. | Q43293820 | ||
The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages | Q44542540 | ||
Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation | Q46225242 | ||
Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages | Q46663320 | ||
Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. | Q55068119 | ||
Purification of an NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from the human placenta | Q68755296 | ||
LKLF: A transcriptional regulator of single-positive T cell quiescence and survival | Q73709468 | ||
ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization | Q22003885 | ||
ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs | Q24290776 | ||
Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis | Q24336781 | ||
Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL | Q24652984 | ||
LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor | Q24656186 | ||
A new description of cellular quiescence | Q25257330 | ||
Metrnl: a secreted protein with new emerging functions | Q26750482 | ||
The biophysics and cell biology of lipid droplets | Q26830071 | ||
Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells | Q28203889 | ||
The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis | Q28271189 | ||
Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
Schlafen, a new family of growth regulatory genes that affect thymocyte development | Q28592251 | ||
Regulation of the mevalonate pathway | Q29547763 | ||
ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation | Q30427703 | ||
12/15-Lipoxygenase activity increases the degradation of macrophage ATP-binding cassette transporter G1. | Q30438268 | ||
Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal | Q33463820 | ||
Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. | Q33608726 | ||
Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. | Q33797113 | ||
An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence | Q33819643 | ||
The epigenetic drug 5-azacytidine interferes with cholesterol and lipid metabolism | Q33846421 | ||
Relationship between sterol synthesis and DNA synthesis in phytohemagglutinin-stimulated mouse lymphocytes | Q35079778 | ||
Liver X Receptor Signaling Pathways in Cardiovascular Disease | Q35104848 | ||
The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function | Q35172754 | ||
Regulation of quiescence in lymphocytes | Q35177712 | ||
Regulation of T-cell survival and mitochondrial homeostasis by TSC1 | Q35621065 | ||
mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation | Q35719914 | ||
Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system. | Q36433762 | ||
Metabolic regulation of T lymphocytes | Q36711431 | ||
Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells | Q36780944 | ||
P433 | issue | 3 | |
P304 | page(s) | 484-493 | |
P577 | publication date | 2017-08-02 | |
P1433 | published in | Immunology | Q15754984 |
P1476 | title | Slfn2 mutation-induced loss of T-cell quiescence leads to elevated de novo sterol synthesis | |
P478 | volume | 152 |
Q88984029 | Slfn2 Regulates Type I Interferon Responses by Modulating the NF-κB Pathway | cites work | P2860 |
Search more.